Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-04 5:21 pm Purchase | 2025-11-01 | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund, L.P. | 3,466,521 6.900% | 1,066,245 (+44.42%) | Filing History |
| 2025-09-30 5:01 pm Purchase | 2025-09-26 | 13D | MBX BIOSCIENCES INC MBX | Frazier Life Sciences Public Fund, L.P. | 5,224,095 11.700% | 666,998 (+14.64%) | Filing History |
| 2025-09-17 5:21 pm Sale | 2025-09-17 | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -10,639,562 (Position Closed) | Filing History |
| 2025-08-20 5:23 pm Sale | 2025-08-18 | 13D | MBX BIOSCIENCES INC MBX | Frazier Life Sciences Public Fund, L.P. | 4,557,097 13.600% | -1,428,250 (-23.86%) | Filing History |
| 2025-08-20 5:20 pm Sale | 2025-08-18 | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund, L.P. | 2,400,276 4.800% | -2,487,591 (-50.89%) | Filing History |
| 2025-08-20 5:18 pm Sale | 2025-08-18 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences Public Fund, L.P. | 5,985,327 8.600% | -8,444,663 (-58.52%) | Filing History |
| 2025-08-14 1:47 pm Purchase | 2025-06-30 | 13G | XILIO THERAPEUTICS INC XLO | Frazier Life Sciences Public Fund, L.P. | 581,501 9.900% | 170,987 (+41.65%) | Filing History |
| 2025-08-14 1:46 pm Sale | 2025-06-30 | 13G | JADE BIOSCIENCES, INC. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,340,703 4.200% | -431,413 (-24.34%) | Filing History |
| 2025-08-14 1:44 pm Sale | 2025-06-30 | 13G | AURA BIOSCIENCES INC AURA | Frazier Life Sciences Public Fund, L.P. | 3,113,550 5.000% | -3,202,128 (-50.70%) | Filing History |
| 2025-08-14 1:43 pm Sale | 2025-06-30 | 13G | MAZE THERAPEUTICS INC MAZE | Frazier Life Sciences Public Fund, L.P. | 3,352,915 7.700% | -1,098,424 (-24.68%) | Filing History |
| 2025-08-14 1:41 pm Sale | 2025-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | Frazier Life Sciences Public Fund, L.P. | 545,504 4.900% | -144,508 (-20.94%) | Filing History |
| 2025-08-14 1:40 pm Sale | 2025-06-30 | 13G | LEXEO THERAPEUTICS INC LXEO | Frazier Life Sciences Public Fund, L.P. | 3,073,467 5.700% | -2,427,345 (-44.13%) | Filing History |
| 2025-08-14 1:39 pm Sale | 2025-06-30 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Frazier Life Sciences Public Fund, L.P. | 32,430,690 4.100% | -7,918,625 (-19.63%) | Filing History |
| 2025-08-14 1:12 pm Sale | 2025-06-30 | 13G | SAVARA INC SVRA | Frazier Life Sciences Public Fund, L.P. | 6,745,296 3.900% | -4,717,005 (-41.15%) | Filing History |
| 2025-08-14 1:11 pm Sale | 2025-06-30 | 13G | DISC MEDICINE INC IRON | Frazier Life Sciences Public Fund, L.P. | 1,026,489 3.000% | -728,345 (-41.51%) | Filing History |
| 2025-08-14 1:10 pm Sale | 2025-06-30 | 13G | ERASCA INC ERAS | Frazier Life Sciences Public Fund, L.P. | 15,038,753 5.300% | -7,537,098 (-33.39%) | Filing History |
| 2025-08-14 1:08 pm Sale | 2025-07-23 | 13G | ELEVATION ONCOLOGY INC ELEV | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -5,993,579 (Position Closed) | Filing History |
| 2025-08-14 1:04 pm Purchase | 2025-08-12 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Frazier Life Sciences Public Fund, L.P. | 1,129,057 5.400% | 87,390 (+8.39%) | Filing History |
| 2025-08-14 1:02 pm Sale | 2025-06-30 | 13G | MACROGENICS INC MGNX | Frazier Life Sciences Public Fund, L.P. | 1,549,193 2.500% | -1,626,472 (-51.22%) | Filing History |
| 2025-06-12 4:55 pm Purchase | 2025-06-05 | 13G | XILIO THERAPEUTICS INC XLO | Frazier Life Sciences Public Fund, L.P. | 410,514 9.900% | 410,514 (New Position) | Filing History |